[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Neuroendocrine Tumor Drug Market Report 2018

June 2018 | 112 pages | ID: A01C22EDC9BEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Neuroendocrine Tumor Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Neuroendocrine Tumor Drug for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Neuroendocrine Tumor Drug market competition by top manufacturers/players, with Neuroendocrine Tumor Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Eisai
  • Exelixis, Inc.
  • Foresee Pharmaceuticals, LLC
  • Hutchison MediPharma Limited
  • Intezyne, Inc
  • INVENT Pharmaceuticals, Inc.
  • Ipsen S.A.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Karyopharm Therapeutics, Inc.
  • Lexicon Pharmaceuticals, Inc.
  • Midatech Pharma Plc.
  • Millennium Pharmaceuticals, Inc.
  • MolMed S.p.A.
  • Northwest Biotherapeutics, Inc.
  • Novartis AG
  • OctreoPharm Sciences GmbH
  • OXiGENE, Inc.
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • mTOR protein inhibitors
  • Tyrosine kinase 3 inhibitors
  • Somatostatin receptor antagonists
  • Growth hormone releasing factor antagonists
  • Somatostatin receptor agonists
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
Asia-Pacific Neuroendocrine Tumor Drug Market Report 2018

1 NEUROENDOCRINE TUMOR DRUG OVERVIEW

1.1 Product Overview and Scope of Neuroendocrine Tumor Drug
1.2 Classification of Neuroendocrine Tumor Drug by Product Category
  1.2.1 Asia-Pacific Neuroendocrine Tumor Drug Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Neuroendocrine Tumor Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 mTOR protein inhibitors
  1.2.4 Tyrosine kinase 3 inhibitors
  1.2.5 Somatostatin receptor antagonists
  1.2.6 Growth hormone releasing factor antagonists
  1.2.7 Somatostatin receptor agonists
  1.2.8 Others
1.3 Asia-Pacific Neuroendocrine Tumor Drug Market by Application/End Users
  1.3.1 Asia-Pacific Neuroendocrine Tumor Drug Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Asia-Pacific Neuroendocrine Tumor Drug Market by Region
  1.4.1 Asia-Pacific Neuroendocrine Tumor Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Neuroendocrine Tumor Drug (2013-2025)
  1.5.1 Asia-Pacific Neuroendocrine Tumor Drug Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC NEUROENDOCRINE TUMOR DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Neuroendocrine Tumor Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Neuroendocrine Tumor Drug Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Neuroendocrine Tumor Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Neuroendocrine Tumor Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Neuroendocrine Tumor Drug (Volume) by Application
2.4 Asia-Pacific Neuroendocrine Tumor Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Neuroendocrine Tumor Drug Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue and Market Share by Region (2013-2018)

3 CHINA NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  3.1.1 China Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  3.1.3 China Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
3.2 China Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
3.3 China Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

4 JAPAN NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  4.1.1 Japan Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
4.2 Japan Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
4.3 Japan Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

5 SOUTH KOREA NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  5.1.1 South Korea Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
5.2 South Korea Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
5.3 South Korea Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

6 TAIWAN NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  6.1.1 Taiwan Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
6.2 Taiwan Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
6.3 Taiwan Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

7 INDIA NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  7.1.1 India Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  7.1.3 India Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
7.2 India Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
7.3 India Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  8.1.1 Southeast Asia Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
8.2 Southeast Asia Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

9 AUSTRALIA NEUROENDOCRINE TUMOR DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Neuroendocrine Tumor Drug Sales and Value (2013-2018)
  9.1.1 Australia Neuroendocrine Tumor Drug Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Neuroendocrine Tumor Drug Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Neuroendocrine Tumor Drug Sales Price Trend (2013-2018)
9.2 Australia Neuroendocrine Tumor Drug Sales Volume and Market Share by Type
9.3 Australia Neuroendocrine Tumor Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC NEUROENDOCRINE TUMOR DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Eisai
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Eisai Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Exelixis, Inc.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Foresee Pharmaceuticals, LLC
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Hutchison MediPharma Limited
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Intezyne, Inc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 INVENT Pharmaceuticals, Inc.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Ipsen S.A.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Jiangsu Hengrui Medicine Co., Ltd.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Karyopharm Therapeutics, Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Lexicon Pharmaceuticals, Inc.
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Midatech Pharma Plc.
10.12 Millennium Pharmaceuticals, Inc.
10.13 MolMed S.p.A.
10.14 Northwest Biotherapeutics, Inc.
10.15 Novartis AG
10.16 OctreoPharm Sciences GmbH
10.17 OXiGENE, Inc.

11 NEUROENDOCRINE TUMOR DRUG MANUFACTURING COST ANALYSIS

11.1 Neuroendocrine Tumor Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Neuroendocrine Tumor Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC NEUROENDOCRINE TUMOR DRUG MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Neuroendocrine Tumor Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Neuroendocrine Tumor Drug Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Neuroendocrine Tumor Drug Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Neuroendocrine Tumor Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Neuroendocrine Tumor Drug Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Neuroendocrine Tumor Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Neuroendocrine Tumor Drug Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Neuroendocrine Tumor Drug Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Neuroendocrine Tumor Drug Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Neuroendocrine Tumor Drug Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Neuroendocrine Tumor Drug Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Neuroendocrine Tumor Drug
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure mTOR protein inhibitors Product Picture
Figure Tyrosine kinase 3 inhibitors Product Picture
Figure Somatostatin receptor antagonists Product Picture
Figure Growth hormone releasing factor antagonists Product Picture
Figure Somatostatin receptor agonists Product Picture
Figure Others Product Picture
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales (K Pcs) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Neuroendocrine Tumor Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Neuroendocrine Tumor Drug Market Size (Million USD) by Region (2013-2025)
Figure China Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Market Major Players Product Sales Volume (K Pcs)(2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Neuroendocrine Tumor Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Neuroendocrine Tumor Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Neuroendocrine Tumor Drug Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Neuroendocrine Tumor Drug Revenue Share by Players
Figure 2017 Asia-Pacific Neuroendocrine Tumor Drug Revenue Share by Players
Table Asia-Pacific Neuroendocrine Tumor Drug Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Neuroendocrine Tumor Drug by Type (2013-2018)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Neuroendocrine Tumor Drug by Type (2013-2018)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Neuroendocrine Tumor Drug by Region (2013-2018)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Market Share by Region in 2017
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Neuroendocrine Tumor Drug by Region (2013-2018)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue Market Share by Region in 2017
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Market Share by Application (2013-2018)
Figure China Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure China Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table China Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table China Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure China Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Figure Japan Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table Japan Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Japan Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Figure South Korea Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure South Korea Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table South Korea Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table South Korea Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure South Korea Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table South Korea Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table South Korea Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure South Korea Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Figure Taiwan Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Taiwan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Taiwan Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Taiwan Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table Taiwan Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Taiwan Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Figure India Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure India Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table India Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure India Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Southeast Asia Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Figure Australia Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Australia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Neuroendocrine Tumor Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Australia Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Australia Neuroendocrine Tumor Drug Sales Volume Market Share by Type (2013-2018)
Figure Australia Neuroendocrine Tumor Drug Sales Volume Market Share by Type in 2017
Table Australia Neuroendocrine Tumor Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Australia Neuroendocrine Tumor Drug Sales Volume Market Share by Application (2013-2018)
Figure Australia Neuroendocrine Tumor Drug Sales Volume Market Share by Application in 2017
Table Eisai Neuroendocrine Tumor Drug Basic Information List
Table Eisai Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eisai Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Eisai Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Eisai Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Exelixis, Inc. Neuroendocrine Tumor Drug Basic Information List
Table Exelixis, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Basic Information List
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Basic Information List
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Intezyne, Inc Neuroendocrine Tumor Drug Basic Information List
Table Intezyne, Inc Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Basic Information List
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Ipsen S.A. Neuroendocrine Tumor Drug Basic Information List
Table Ipsen S.A. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Basic Information List
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Basic Information List
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Basic Information List
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Midatech Pharma Plc. Neuroendocrine Tumor Drug Basic Information List
Table Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Basic Information List
Table MolMed S.p.A. Neuroendocrine Tumor Drug Basic Information List
Table Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Basic Information List
Table Novartis AG Neuroendocrine Tumor Drug Basic Information List
Table OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Basic Information List
Table OXiGENE, Inc. Neuroendocrine Tumor Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuroendocrine Tumor Drug
Figure Manufacturing Process Analysis of Neuroendocrine Tumor Drug
Figure Neuroendocrine Tumor Drug Industrial Chain Analysis
Table Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2017
Table Major Buyers of Neuroendocrine Tumor Drug
Table Distributors/Traders List
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue Market Share Forecast by Region in 2025
Figure China Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South Korea Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Taiwan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Neuroendocrine Tumor Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Australia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Neuroendocrine Tumor Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Neuroendocrine Tumor Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Asia-Pacific Neuroendocrine Tumor Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Asia-Pacific Neuroendocrine Tumor Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories